Hormone Replacement Therapy

1. Brain Fog: This term describes the cognitive symptoms many women experience during menopause, including memory lapses, trouble concentrating, and difficulty processing information. These cognitive changes are often linked to fluctuating hormone levels and can make daily tasks feel more challenging.

2. Period Changes: For many women, changes in their menstrual cycle are the first noticeable sign of menopause. Periods may become irregular, lighter or heavier, or less frequent before they stop altogether.

3. Loss of Sexual Desire: Decreased libido is a common symptom during menopause, influenced by hormonal changes, particularly the decline in testosterone levels, which play a role in sexual desire. Additionally, physical symptoms like vaginal dryness, night sweats, and fatigue can contribute to this decrease in sexual interest.

4. Night Sweats: These are intense, sudden feelings of heat during the night, often accompanied by sweating so severe that it requires changing clothes or bed sheets. Night sweats are a common symptom caused by hormonal fluctuations.

5. Fatigue and Poor Sleep: Hormonal changes, particularly night sweats and hot flashes, can severely impact the quality of sleep, leading to daytime fatigue. Even if sleep isn’t directly interrupted, overall energy levels may decrease, and feeling exhausted during the day is common.

6. Hot Flushes: Sudden waves of heat, which often spread from the face and chest throughout the body, are another hallmark symptom of menopause. Hot flushes can last anywhere from a few seconds to several minutes and can happen at any time of the day or night.

7. Mood Changes: Hormonal shifts can lead to mood swings, including feelings of irritability, anxiety, or sudden bouts of anger. These emotional changes can be disruptive and affect personal relationships, work life, and overall well-being.

8. Migraines: Hormonal changes can trigger migraines or make them worse.

9. Joint Pain: Some women report an increase in joint pain or stiffness during menopause.

10. Hair and Skin Changes: Thinning hair, dry skin, and changes in skin elasticity are also commonly reported.

11. Vaginal and Urinary Symptoms: These can include vaginal dryness, discomfort during sex, and urinary frequency or urgency.

These symptoms can vary widely from woman to woman in terms of severity and duration. While the symptoms can be challenging, there are treatments and lifestyle changes that can help manage them. Hormone replacement therapy (HRT), dietary changes, exercise, and mindfulness or relaxation techniques are often used to ease symptoms.

If you're experiencing any of these symptoms and they're affecting your daily life, schedule a consultation today.

1. Oral Estrogen (Tablets): When estrogen is taken orally, it passes through the liver before entering the bloodstream. This process leads to the production of clotting factors, which increases the risk of developing blood clots or strokes, especially in women who already have a higher risk for these conditions.

2. Transdermal Estrogen (Patch, Gel, or Spray): Estrogen delivered through the skin via a patch, gel, or spray avoids the liver and enters the bloodstream directly, bypassing the metabolic effects that can lead to clotting factors. As a result, the risk of blood clots or stroke is lower, making transdermal estrogen a safer option for women with a higher risk of clotting or those who have experienced a clot in the past.

3. Progesterone Use: For women who still have a uterus, adding progesterone is necessary to prevent the thickening of the uterine lining, which could lead to endometrial cancer. There are two main types of progesterone:

   • Micronised Progesterone: This is the safer option as it is not associated with an increased risk of clot formation.

   • Synthetic Progestogens: These older forms of progesterone have been linked to a slightly higher risk of clot formation.

In conclusion, transdermal estrogen (patch, gel, spray) may be a better option for women with high blood pressure, as it has a more favorable effect on blood pressure compared to oral estrogen. Micronised progesterone is also a safer choice in terms of its impact on blood pressure. Regular monitoring by a doctor is key to managing both HRT and blood pressure effectively.

1. Misleading Risk Information: The product leaflets for transdermal estrogen (patch, gel, spray) and micronised progesterone often carry risk warnings about blood clots, heart disease, stroke, and breast cancer. However, this information is largely based on the risks associated with oral synthetic estrogen, which does carry a small increased risk of clots, heart disease, stroke, and breast cancer. Transdermal estrogen, on the other hand, bypasses the liver and doesn't carry the same risks. Likewise, micronised progesterone doesn't carry the same risk of clotting as synthetic progestogens.

2. The Need for Updated Leaflets: The leaflets were originally written to describe the risks of oral synthetic estrogen, which has different pharmacokinetics and side effects compared to transdermal estrogen. Ideally, product inserts should be updated to reflect the specific medication in the box. For example, transdermal estrogen should not include the same clotting risk warnings as oral estrogen, and micronised progesterone should not carry the same risks of clotting associated with older synthetic progestogens.

3. Why This Matters: When patients rely on outdated or inaccurate information from product leaflets, they may be unnecessarily concerned about risks or even avoid effective treatments that could improve their health. Clear, accurate, and up-to-date information is crucial for informed decision-making, especially in the context of hormone replacement therapy.

In summary, the risk information in the inserts for transdermal estrogen and micronised progesterone should be updated to accurately reflect the safety profiles of these medications. This would help patients and healthcare providers make more informed decisions and avoid unnecessary confusion or concerns.

For the vast majority of women, the benefits of HRT outweigh the risks. HRT can significantly alleviate symptoms of menopause like hot flashes, night sweats, fatigue, and mood changes, as well as protect against osteoporosis. However, the risks of HRT can vary based on the type of HRT used, the woman’s age, general health, and her individual risk factors.

Breast Cancer Risk

• Estrogen and Progestogen (Synthetic): Combined HRT that contains both estrogen and a synthetic progestogen (a form of synthetic progesterone) has been linked to a very small increased risk of breast cancer. This increased risk is primarily due to the synthetic progestogen, not the estrogen.

• Micronised Progesterone (Body-Identical Progesterone): When HRT includes micronised progesterone (the form of progesterone that is identical to what the body produces), there is no increased risk of breast cancer. This makes micronised progesterone a safer choice in terms of breast cancer risk.

Even in cases where synthetic progestogens are used, the increased risk of breast cancer remains very low. It’s also worth noting that the risk of breast cancer associated with synthetic progestogen is lower than the risk posed by lifestyle factors, such as drinking alcohol regularly or being overweight.

Other Risks of HRT

• Blood Clots: If estrogen is taken in oral tablet form, there is a small increased risk of developing a blood clot. However, this risk does not apply when estrogen is taken transdermally (via patch, gel, or spray), as these forms bypass the liver, where clotting factors are produced.

• Age and HRT Use:

  • If you have had a hysterectomy (removal of the uterus), and you are taking only estrogen, your risk of breast cancer is lower than if you didn’t take HRT at all.

  • For women under 51, studies have shown there is no increased risk of breast cancer from taking any type of HRT, regardless of whether it is combined with a progestogen or not.

Since the risk of breast cancer depends on various individual factors (such as family history, age, general health, and type of HRT), it’s essential to have a personalized consultation with your doctor. Your doctor can help determine your actual risks and provide tailored advice on the most appropriate type of HRT for you.

• Most types of HRT do not significantly increase the risk of breast cancer.

• The small increased risk of breast cancer is primarily linked to the type of progestogen used (with synthetic progestogens carrying a slight risk).

• Micronised progesterone, a body-identical form of progesterone, does not increase the risk of breast cancer.

• If you've had a hysterectomy and are taking only estrogen, your risk of breast cancer is lower than if you didn't use HRT.

• Transdermal estrogen (patch, gel, spray) does not carry an increased risk of blood clots compared to oral tablets.

Ultimately, while there are some risks associated with HRT, for most women, the benefits far outweigh the risks, especially when tailored to the individual’s needs and health profile. Always consult with a healthcare professional to ensure the best choice for your health.

• Genetic/Familial Cause: While breast cancer is relatively common, it’s important to note that only about 10% of breast cancers are caused by genetic or familial factors. Therefore, having a family history of breast cancer does not automatically mean you will develop it.

• Lifetime Risk: The general lifetime risk for any woman to develop breast cancer is around 1 in 7. This means that 1 in 7 women will be diagnosed with breast cancer, regardless of whether they take HRT, due to the natural risk of the disease.

• Family History and HRT: There is no strong evidence that having a family history of breast cancer increases your risk of developing breast cancer if you take HRT, compared to women who don’t have a family history. In fact, some evidence suggests that women with a family history of breast cancer who take HRT might actually have a lower future risk of developing breast cancer compared to those not on HRT.

• Women with BRCA Genes: Even women who have a BRCA gene (a genetic mutation linked to higher breast cancer risk) can often safely take HRT, but this should always be discussed with their doctor, as each case is unique.

• Safety of HRT: Most women with a family history of breast cancer can still safely take HRT. The potential benefits of HRT, such as relief from menopause symptoms, osteoporosis protection, and overall well-being, typically outweigh the risks for many women. HRT is often safe to take for an extended period, and there is no need to stop taking it at a specific age or after a certain length of time, unless advised by a healthcare provider based on individual health factors.

• Breast Cancer Risk and HRT: Most women who have a family history of breast cancer do not develop breast cancer, even if they take HRT. The risks from HRT are generally low and are similar to the risks posed by lifestyle factors, such as alcohol consumption and weight.

While there is no guaranteed way to prevent breast cancer, several lifestyle factors can help lower the risk:

• Maintain a healthy weight

• Exercise regularly

• Avoid smoking

• Limit alcohol consumption as much as possible

• Perform regular breast self-exams to detect any changes in your breast tissue, such as lumps or skin changes.

For women with a family history of breast cancer, it’s crucial to have a personalized consultation with a healthcare provider to assess their individual risks and decide the best course of action regarding HRT. The overall evidence suggests that, for most women, the benefits of HRT outweigh the risks—especially when used responsibly and under medical guidance. By adopting a healthy lifestyle and staying vigilant with regular breast checks, women can manage their breast cancer risk while enjoying the benefits of HRT.